Upcoming
| Past
|
LOOKING FOR AIR? ALL ABOUT RESPIRATORY SYNCYTIAL VIRUS (RSV)
|
08/24/2024
|
2.00 |
|
USP 797 & 800 COMPLIANCE: PATHWAYS TO COMPETENCY AND ACCREDITATION ESSENTIALS
|
08/24/2024
|
2.00 |
|
FOCUSING ON WOMEN ISSUES: REPRODUCTIVE CARE, PREGNANCY AND LACTATION
|
08/24/2024
|
2.00 |
|
SO MANY LAWS AND AMENDMENTS: PHARMACY LAW UPDATE 2024
|
08/24/2024
|
2.00 |
|
DRUG SUPPLY CHAIN SECURITY ACT (DSCSA) REQUIREMENTS AND IMPLEMENTATION PEARLS
|
08/23/2024
|
2.00 |
|
IMMUNIZATION UPDATES 2024
|
08/23/2024
|
2.00 |
|
NAVIGATING CYBERSECURITY IN PHARMACY
|
08/23/2024
|
2.00 |
|
THE ROLE OF AI IN MODERNIZING PHARMACY PRACTICE: CHALLENGES AND OPPORTUNITIES
|
08/23/2024
|
2.00 |
|
AN UPDATE ON INFLATION REDUCTION ACT IRA: WHAT’S NEXT?
|
08/23/2024
|
2.00 |
|
DON’T BE CONFUSED WITH NUTRITIONAL SUPPLEMENTS: USE AND EXPECTATIONS OF THESE SUPPLEMENTS
|
08/23/2024
|
2.00 |
|
CLINICAL PEARLS IN TOXICOLOGY AND THE ROLE OF THE CLINICAL PHARMACIST IN THE EMERGENCY DEPARTMENT
|
08/22/2024
|
2.00 |
|
EPA, CAPE-EO, COEPA: ALPHABET SOUP FOR PRECEPTORS
|
08/22/2024
|
2.00 |
|
INFINITE WORK: A SYSTEMIC APPROACH TO THE ADDRESS BURNOUT SYNDROME
|
08/22/2024
|
2.00 |
|
PREVENTION AND MANAGEMENT OF PATIENTS WITH CARDIO- RENAL-METABOLIC COMORBIDITIES
|
08/22/2024
|
2.00 |
|
DEALING WITH OBESITY AND HOW TO MANAGE YOUR MENTAL
|
08/22/2024
|
2.00 |
|
DIABETES AND NUTRITION MANAGEMENT: CHALLENGES AND OPPORTUNITIES
|
08/22/2024
|
2.00 |
|
GENDER VIOLENCE: HOW CAN WE IDENTIFY, PREVENT AND MANAGE IT IN THE WORKPLACE
|
08/22/2024
|
2.00 |
|
BIOSIMILARS: WHERE DO WE STAND
|
07/31/2024
- 09/29/2024
|
1.00 |
|
PREVENTING MEDICATION ERRORS 2024
|
07/26/2024
|
2.00 |
|
A FINANCIAL ANALYSIS OF HOW TO ESTABLISH A COMPARABLE FOR THE YEARS 2022, 2023, AND 2024
|
04/19/2024
|
1.50 |
|
IN ADDITION TO LOSING WEIGHT: DISCOVER THE SECRETS, BENEFITS AND RISKS OF SEMAGLUTIDE, TIRZEPATIDE AND LIRAGLUTIDE
|
04/14/2024
- 04/20/2024
|
2.00 |
|
THE LEADER THAT EVERYONE NEED
|
03/09/2024
|
3.00 |
|
COMMITED MEMBERS OF THE COLEGIO DE FARMACEUTICOS DE PR: EFFICIENCY, TRUSTWORTHINESS AND PROCEEDINGS
|
03/09/2024
|
2.50 |
|
PATIENT CENTERED APPROACH THAT FACILITATES ACCESS AND ADHERENCE TO MEDICATIONS
|
02/24/2024
|
1.50 |
|
STATISTICS AND A CONDUCTIVE METHOD FOR AUDITING YOURSELF BEFORE BEING FLAGGED BY A PBM
|
01/27/2024
|
3.00 |
|
CONDUCTIVE METHOD THAT CAN HELP US IN PBM COMPLIANCE
|
01/27/2024
|
3.00 |
|
USP 797 CHANGE IS HERE
|
01/27/2024
|
3.00 |
|
CYBERSECURITY IN THE ERA OF ARTIFICIAL INTELLIGENCE: CHALLENGES AND OPORTUNITIES
|
10/29/2023
|
1.00 |
|
UPDATE ON THE 2022 CDC CLINICAL PRACTICE GUIDELINE FOR PAIN MANAGEMENT
|
08/26/2023
|
2.00 |
|
WHAT SHOULD PHARMACISTS KNOW ABOUT OPTIMIZING CARE FOR PATIENTS WITH PERIPHERAL ARTERY DISEASE AND VENOUS INSUFFICIENCY?
|
08/26/2023
|
2.00 |
|
HOW TO ESTABLISH A FINANCIAL ANALYSIS USING A PHARMACY COMPUTER SYSTEM
|
08/26/2023
- 10/10/2023
|
2.00 |
|
NONTRADITIONAL TREATMENTS: HOMEOPATHY AND HORMONE REPLACEMENT THERAPY
|
08/26/2023
|
2.00 |
|
PEARLS IN GERIATRIC CARE: FALL RISK PREVENTION AND SLEEP DISORDERS MANAGEMENT
|
08/26/2023
|
2.00 |
|
PUERTO RICO PHARMACY LAW REVIEW: OBLIGATIONS AND RIGHTS OF PHARMACISTS IN THE INSPECTION PROCESS
|
08/26/2023
|
3.00 |
|
FOUNDATION OF PHARMACY COMPOUNDING AND THE USP <795> AND <800>
|
08/26/2023
|
3.00 |
|
IMMUNIZATION UPDATES 2023
|
08/25/2023
|
2.00 |
|
WHAT SHOULD I KNOW ABOUT THE 2022 AHA/ACC/HFSA HEART FAILURE MANAGEMENT GUIDELINES
|
08/25/2023
|
2.00 |
|
CYBERSECURITY THREATS IN THE PHARMACY SECTOR
|
08/25/2023
|
2.00 |
|
DIFFICULT CONVERSATIONS: THE EFFECT OF COMMUNICATION SKILLS IN THE PATIENT-PHARMACIST RELATIONSHIP AND HOW TO MANAGE DIFFICULT SITUATION
|
08/25/2023
|
2.00 |
|
MEDICARE AND THE IRA REGULATIONS/ UNDERSTANDING HEALTHCARE PROVISIONS OF THE INFLATION REDUCTION ACT AND THE IMPACT ON HEALTHCARE ECOSYSTEM
|
08/25/2023
|
2.00 |
|
LABOR REFORM: WHAT IS THE IMPACT ON PHARMACY?
|
08/25/2023
|
2.00 |
|
HIV PRE-EXPOSURE PROPHYLAXIS (PREP) CLINICAL UPDATES
|
08/25/2023
|
2.00 |
|
ETHICAL CONSIDERATIONS WHILE REDUCING HEALTH DISPARITIES IN THE LGBTQ+ COMMUNITY
|
08/25/2023
|
3.00 |
|
UPDATES ON COPD MANAGEMENT: THE GOLD GUIDELINES
|
08/24/2023
|
2.00 |
|
IMPACT OF SOCIAL DETERMINANTS IN DIABETES MELLITUS PREVENTION AND MANAGEMENT: COMMUNITY AND AMBULATORY CARE APPROACH
|
08/24/2023
|
2.00 |
|
ACHIEVING A NORMAL WEIGHT: THE STRATEGIES AND PHARMACOTHERAPY THAT WILL HELP
|
08/24/2023
|
2.00 |
|
WORKING AND PRECEPTING A DIFFERENT GENERATION OF LEARNERS AND PRACTITIONERS
|
08/24/2023
|
2.50 |
|
BASIC COMMUNICATION IN AMERICAN SIGN LANGUAGE FOR PHARMACY
|
08/24/2023
|
2.00 |
|
NOVEL APPROACHES IN THE MANAGEMENT OF ALZHEIMER DISEASE: CONSIDERATIONS FOR PHARMACISTS AND PHARMACY TECHNICIANS
|
08/24/2023
|
2.00 |
|
BIOSIMILAR EXPANSION ERA: A REVIEW OF REGULATIONS AND DISPENSING ISSUES
|
08/24/2023
|
2.00 |
|
MEDICATION ERRORS 2023
|
08/24/2023
|
3.00 |
|
DRUG TRACE - PHARMACY REQUIREMENTS EFFECTIVE NOV 27, 2023
|
06/02/2023
|
3.00 |
|
HOW TO RUN YOUR PHARMACY
|
06/02/2023
|
2.00 |
|
NON – STERILE COMPOUNDING IN PEDIATRICS
|
05/04/2023
|
3.00 |
|
NON – STERILE COMPOUNDING FOR DERMATOLOGY
|
04/15/2023
|
3.00 |
|
NON-STERILE COMPOUNDING IN GASTROENTEROLOGY
|
03/11/2023
|
3.00 |
|
LEADERSHIP FOR THE PHARMACEUTICAL PROFESSIONAL
|
03/11/2023
|
3.00 |
|
MEDICATION SAFETY: A QUALITY AND RISK / FAILURE MANAGEMENT APPROACH
|
03/03/2023
|
2.00 |
|
NON-STERILE COMPOUNDING FOR PHARMACY & PHARMACY TECHNICIANS (PART. 3)
|
11/20/2022
|
6.00 |
|
NON-STERILE COMPOUNDING FOR PHARMACY & PHARMACY TECHNICIANS (PART. 2)
|
11/19/2022
|
6.00 |
|
NON-STERILE COMPOUNDING FOR PHARMACY & PHARMACY TECHNICIANS (PART. 1)
|
11/18/2022
|
6.00 |
|
HOW TO REDUCE PATIENT’S RISKS? PEARLS IN MEDICATION SAFETY
|
08/20/2022
|
2.00 |
|
UPDATE IN PHARMACY LAWS
|
08/20/2022
|
3.00 |
|
CLINICAL PEARLS: PHARMACISTS COMMITMENT IN ANTIMICROBIAL AND OPIOID STEWARDSHIP PROGRAMS
|
08/20/2022
|
2.00 |
|
OPTIMIZATION OF NON-OPIOIDS ANALGESICS: FROM THE THEORY TO THE PRACTICE
|
11/30/2020
|
1.50 |
Loading, please wait...